Literature DB >> 27299579

Acute Kidney Injury After Intravenous Versus Intra-Arterial Contrast Material Administration in a Paired Cohort.

Jennifer S McDonald1, Caleb B Leake, Robert J McDonald, Rajiv Gulati, Richard W Katzberg, Eric E Williamson, David F Kallmes.   

Abstract

OBJECTIVES: The aim of this study was to determine whether intra-arterial administration of contrast material is associated with a higher risk of acute kidney injury (AKI) compared with that of intravenous (IV) administration in a cohort of patients that received both routes of administration.
MATERIALS AND METHODS: All patients who received both a contrast-enhanced computed tomography (CT) and a diagnostic or interventional cardiac catheterization between 2000 and 2014 were identified. Patients who lacked sufficient preprocedure and postprocedure serum creatinine results, who were on preexisting renal dialysis, or who underwent additional contrast-enhanced procedures within 7 days of either procedure were excluded. The rate of AKI (serum creatinine ≥0.3 mg/dL or 50% above baseline) was compared after CT scan and cardiac catheterization using McNemar test.
RESULTS: A total of 1969 patients met all study inclusion criteria. The rate of AKI after CT scan was similar to the rate after catheterization when examining all patients (9.9% CT vs 11% catheterization, P = 0.12). A similar rate of AKI after both procedures was observed regardless of procedure order, catheterization type, and patient baseline estimated glomerular filtration rate.
CONCLUSIONS: Intra-arterial administration of contrast material during cardiac catheterization had a similar risk of AKI as compared with that of CT scanning involving IV administration in a cohort of patients who underwent both procedures. These findings suggest that previously reported much higher rates of AKI after cardiac catheterization compared with that of IV contrast administration reflect higher baseline clinical risk factors for AKI in the former cohort compared with that in the latter.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27299579     DOI: 10.1097/RLI.0000000000000298

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  16 in total

1.  Guideline on the use of iodinated contrast media in patients with kidney disease 2018.

Authors:  Yoshitaka Isaka; Hiromitsu Hayashi; Kazutaka Aonuma; Masaru Horio; Yoshio Terada; Kent Doi; Yoshihide Fujigaki; Hideo Yasuda; Taichi Sato; Tomoyuki Fujikura; Ryohei Kuwatsuru; Hiroshi Toei; Ryusuke Murakami; Yoshihiko Saito; Atsushi Hirayama; Toyoaki Murohara; Akira Sato; Hideki Ishii; Tadateru Takayama; Makoto Watanabe; Kazuo Awai; Seitaro Oda; Takamichi Murakami; Yukinobu Yagyu; Nobuhiko Joki; Yasuhiro Komatsu; Takamasa Miyauchi; Yugo Ito; Ryo Miyazawa; Yoshihiko Kanno; Tomonari Ogawa; Hiroki Hayashi; Eri Koshi; Tomoki Kosugi; Yoshinari Yasuda
Journal:  Clin Exp Nephrol       Date:  2020-01       Impact factor: 2.801

2.  Preventing contrast medium-induced acute kidney injury : Side-by-side comparison of Swedish-ESUR guidelines.

Authors:  Ulf Nyman; Joanna Ahlkvist; Peter Aspelin; Torkel Brismar; Anders Frid; Mikael Hellström; Per Liss; Gunnar Sterner; Peter Leander
Journal:  Eur Radiol       Date:  2018-08-21       Impact factor: 5.315

3.  Guideline on the use of iodinated contrast media in patients with kidney disease 2018.

Authors:  Yoshitaka Isaka; Hiromitsu Hayashi; Kazutaka Aonuma; Masaru Horio; Yoshio Terada; Kent Doi; Yoshihide Fujigaki; Hideo Yasuda; Taichi Sato; Tomoyuki Fujikura; Ryohei Kuwatsuru; Hiroshi Toei; Ryusuke Murakami; Yoshihiko Saito; Atsushi Hirayama; Toyoaki Murohara; Akira Sato; Hideki Ishii; Tadateru Takayama; Makoto Watanabe; Kazuo Awai; Seitaro Oda; Takamichi Murakami; Yukinobu Yagyu; Nobuhiko Joki; Yasuhiro Komatsu; Takamasa Miyauchi; Yugo Ito; Ryo Miyazawa; Yoshihiko Kanno; Tomonari Ogawa; Hiroki Hayashi; Eri Koshi; Tomoki Kosugi; Yoshinari Yasuda
Journal:  Jpn J Radiol       Date:  2020-01       Impact factor: 2.374

Review 4.  Understanding and preventing contrast-induced acute kidney injury.

Authors:  Michael Fähling; Erdmann Seeliger; Andreas Patzak; Pontus B Persson
Journal:  Nat Rev Nephrol       Date:  2017-01-31       Impact factor: 28.314

5.  Impact of Contrast-Induced Nephropathy on Long-Term Renal Function after Coronary Angiography and Contrast-Enhanced Computed Tomography.

Authors:  Hidekazu Moriya; Yasuhiro Mochida; Kunihiro Ishioka; Machiko Oka; Kyoko Maesato; Mizuki Yamano; Hiroyuki Suzuki; Takayasu Ohtake; Sumi Hidaka; Shuzo Kobayashi
Journal:  Cardiol Cardiovasc Med       Date:  2022-09-16

6.  Renal immune surveillance and dipeptidase-1 contribute to contrast-induced acute kidney injury.

Authors:  Arthur Lau; Hyunjae Chung; Takanori Komada; Jaye M Platnich; Christina F Sandall; Saurav Roy Choudhury; Justin Chun; Victor Naumenko; Bas Gj Surewaard; Michelle C Nelson; Annegret Ulke-Lemée; Paul L Beck; Hallgrimur Benediktsson; Anthony M Jevnikar; Sarah L Snelgrove; Michael J Hickey; Donna L Senger; Matthew T James; Justin A Macdonald; Paul Kubes; Craig N Jenne; Daniel A Muruve
Journal:  J Clin Invest       Date:  2018-06-04       Impact factor: 14.808

7.  Identification of novel therapeutic targets for contrast induced acute kidney injury (CI-AKI): alpha blockers as a therapeutic strategy for CI-AKI.

Authors:  Sreenivasulu Kilari; Amit Sharma; Chenglei Zhao; Avishek Singh; Chuanqi Cai; Michael Simeon; Andre J van Wijnen; Sanjay Misra
Journal:  Transl Res       Date:  2021-03-09       Impact factor: 10.171

Review 8.  Post-contrast acute kidney injury - Part 1: Definition, clinical features, incidence, role of contrast medium and risk factors : Recommendations for updated ESUR Contrast Medium Safety Committee guidelines.

Authors:  Aart J van der Molen; Peter Reimer; Ilona A Dekkers; Georg Bongartz; Marie-France Bellin; Michele Bertolotto; Olivier Clement; Gertraud Heinz-Peer; Fulvio Stacul; Judith A W Webb; Henrik S Thomsen
Journal:  Eur Radiol       Date:  2018-02-09       Impact factor: 5.315

9.  Post-contrast acute kidney injury in a hospitalized population: short-, mid-, and long-term outcome and risk factors for adverse events.

Authors:  Wei Cheng; Xi Wu; Qian Liu; Hong-Shen Wang; Ning-Ya Zhang; Ye-Qing Xiao; Ping Yan; Xu-Wei Li; Xiang-Jie Duan; Jing-Cheng Peng; Song Feng; Shao-Bin Duan
Journal:  Eur Radiol       Date:  2020-02-21       Impact factor: 5.315

10.  Novel 4D-MRI of tumor infiltrating vasculature: characterizing tumor and vessel volume motion for selective boost volume definition in pancreatic radiotherapy.

Authors:  Wensha Yang; Zhaoyang Fan; Zixin Deng; Jianing Pang; Xiaoming Bi; Benedick A Fraass; Howard Sandler; Debiao Li; Richard Tuli
Journal:  Radiat Oncol       Date:  2018-10-01       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.